Difebarbamate(INN) is atranquilizerof thebarbiturateandcarbamatefamilies which is used inEuropeas a component of acombination drugformulationreferred to astetrabamate(Atrium,Sevrium).[1][2][3]
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.036.147 |
Chemical and physical data | |
Formula | C28H42N4O9 |
Molar mass | 578.663g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^Index nominum 2000: international drug directory.Taylor & Francis US. 2000. p. 333.ISBN978-3-88763-075-1.Retrieved26 November2011.
- ^World Health Organization (2004)."The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance"(PDF).
- ^Vachta J, Valter K, Siegfried B (1990). "Metabolism of difebarbamate in man".European Journal of Drug Metabolism and Pharmacokinetics.15(3): 191–8.doi:10.1007/BF03190203.PMID2253648.S2CID2916646.